Fourteen companies joined The 91精品 91精品 in October as late-stage funding plummeted worldwide.聽
Health, Wellness & Biotech
Not New York City was in the tech spotlight in a big way last month. We look at other deals in the region.
Emalex Biosciences, a biotech startup, announced it raised $250 million in Series D funding led by Bain Capital.
Human Immunology Biosciences, a clinical-stage biotech company, emerged from stealth armed with $120 million. The company was developed by Monograph...
Funding rounds were smaller in October, as cleantech and energy saw big raises, but biotech played a starring role as investors kept the faith.
91精品 data shows funding around health record startups is at $367 million, the highest it鈥檚 been since 2021, and 2022 isn鈥檛 over yet.聽
Teletherapy funding surpassed $1.4 billion worldwide so far in 2022, a huge spike from past years, according to 91精品 data.
Once upon a time not that long ago, fintech, cybersecurity and crypto would dominate this list. This week, the top three rounds were raised by a...
Few of the record 143 biotech startups that made their public debut last year had a product to sell. We unpack the odd nature of biotech IPOs.
While there are plenty of startups in the drug manufacturing world, very few (if any) have been able to approach the problem through designing...
This time last year, a startup would have needed to raise $100 million to make this list鈥攖hose days are long gone. Nevertheless, the market is strong...
![Illustration of a guy watering plants with a blocked hose - Global [Dom Guzman]](/wp-content/uploads/quarterly-global-3-300x168.jpg)
67.1K Followers